Abeona Therapeutics Inc.
ABEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $286 | $298 | $237 | $229 |
| - Cash | $83 | $164 | $16 | $23 |
| + Debt | $24 | $24 | $24 | $23 |
| Enterprise Value | $228 | $159 | $245 | $228 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | 75% | – | – |
| EBITDA | -$19 | $126 | -$10 | -$7 |
| % Margin | – | 31,517.5% | – | – |
| Net Income | -$5 | $109 | -$12 | -$9 |
| % Margin | – | 27,208.3% | – | – |
| EPS Diluted | -0.1 | 1.71 | -0.24 | -0.23 |
| % Growth | -105.8% | 812.5% | -4.3% | – |
| Operating Cash Flow | -$21 | -$19 | -$18 | -$17 |
| Capital Expenditures | -$3 | -$3 | -$1 | -$1 |
| Free Cash Flow | -$24 | -$22 | -$20 | -$17 |